273例女性精神病患者用药状况分析  

Medication analysis for 273 female psychiatric patients

作　　者：苏亚梅 刘铭涛 罗传琳 

机构地区：[1]普洱市第二人民医院,云南普洱665000

出　　处：《中国民康医学》2013年第11期20-22,共3页Medical Journal of Chinese People’s Health

摘　　要：目的:探讨女性精神病患者用药状况。方法:通过自制调查表,调查普洱市第二人民医院273例女性精神病患者用药状况,并进行统计分析。结果:女性精神病患者单一用药下降明显,联合用药有上升趋势。新型抗精神病药物成为女性患者用药的主导地位。阿立哌唑联用利培酮频率高。女性精神病患者联用抗抑郁药频率高。结论:新型抗精神病药物由于其安全性,高效性已成为我院女性精神病患者的主要用药。Objective：To explore medication situations for female psychiatric patients. Methods：Through self- made ques- tionnaire, the medication situations of 273 female psychiatric patients were investigated and statistically analyzed. Results： Rate of sin- gle drug for the female psychiatric patients in our hospital declined significantly, whereas that of combined drug increased gradually. For the female psychiatric patients, new antipsychotic drugs were the main drugs, wherein aripiprazole combined with risperidone was used with a high frequency. And also, the use frequency of combined antidepressant was high. Conclusions： New antipsychotic drugs have become the major drugs for female psychiatric patients in our hospital due to their safety and high efficiency.

关 键 词：女性精神病患者 新型抗精神病药物 新型抗抑郁药物 用药分析 

分 类 号：R749[医药卫生—神经病学与精神病学]